Anterior Approach for Major Right Hepatic
Resection for Large Hepatocellular Carcinoma
Chi-Leung Liu , MBBS, FRCS(Edin); Sheung-Tat Fan, MS, MD, FRCS(Glasg,
Edin), FACS; Chung-Mau Lo, MS, FRACS, FRCS(Edin), FACS;
Ronnie Tung-Ping Poon, MS, FRCS(Edin); John Wong PhD, FRACS, FRCS(Edin),
FACS
Objective
To report the surgical and long-term outcomes of major right hepatic
resection for large hepatocellular carcinoma (HCC) using the anterior approach
compared with the conventional approach.
Summary Background Data
Great difficulty can be encountered during major right hepatic resection
for large HCC using the conventional approach. Forceful retraction during
mobilization of the tumor might result in serious complications, including
dissemination of cancer cells, iatrogenic tumor rupture, and excessive
bleeding, leading to unfavorable surgical and long-term outcomes.
Methods
In patients who had large HCC at the right lobe of liver and underwent
major hepatic resection, the technique of anterior approach was used. After
hilar control of the inflow blood vessels and without prior mobilization of
the right lobe of liver and the tumor, parenchymal transection was performed
using an ultrasonic dissector from the anterior surface of the liver until the
anterior surface of the inferior vena cava was exposed. All venous
tributaries, including the right hepatic vein, were controlled before the
right lobe of liver was mobilized. Surgical and long-term outcomes were
analyzed retrospectively and compared with patients who underwent surgery
using the conventional approach.
Results
From 1989 to 1997, the anterior approach was used for major right hepatic
resection in 54 patients with HCC of 5 cm or more in diameter. When compared
with the 106 patients with similar clinical parameters who underwent hepatic
resection using the conventional approach during the same period, the patients
in the anterior approach group had significantly less intraoperative blood
loss and blood transfusion, a lower hospital death rate, a lower incidence of
pulmonary metastases, and a better median disease-free survival and median
overall cumulative survival.
Conclusion
The anterior approach is the preferred technique for major right hepatic
resection for large HCC because it resulted in improved surgical and survival
outcomes compared with the conventional approach.
During right hepatic resection for hepatocellular carcinoma (HCC), complete
mobilization of the right lobe of liver with the right hepatic vein controlled
outside the liver before parenchymal transection has been advised by most
surgeons,1-4
and this conventional approach has been suggested to be helpful in reducing the
amount of surgical blood loss.5
However, the conventional approach may not be feasible in some patients with
large HCC undergoing major right hepatic resection. The tumor may infiltrate
into the surrounding structures, and the size of the tumor may limit access to
the posterior aspect of the right lobe of liver and the anterior surface of the
inferior vena cava, where the right hepatic vein and many caval branches are
present. Injudicious mobilization of the liver may carry theoretical risks of
excessive bleeding from avulsion of the hepatic vein and caval branches,
prolonged ischemia of the liver remnant from rotation of the hepatoduodenal
ligament,6
iatrogenic tumor rupture, and spillage of cancer cells into the systemic
circulation. Alternatively, the anterior approach can be adopted for patients
requiring difficult major right hepatic resection for HCC. The technique
involves initial completion of parenchymal transection before the right lobe is
mobilized. Our initial experience of the anterior approach in a heterogeneous
group of patients with large right-lobe liver tumors, including benign and
malignant ones, showed that it was a safe and effective option for selected
patients undergoing major right hepatic resection.7
However, the theoretic advantages of the anterior approach over the conventional
approach in patients with large HCC have not been documented. In the present
study, the surgical and long-term outcomes of hepatic resection for large
right-lobe HCC using the anterior approach are compared with the conventional
approach.
METHODS
A retrospective study was performed on all patients who underwent major right
hepatic resection from January 1989 to December 1997 for HCC 5 cm or more in
diameter. Major hepatic resection was defined as resection of three or more
liver segments according to the Couinaud nomenclature.8
The clinical data of all patients were recorded prospectively in a computerized
database by a single research assistant. All patients followed the same
preoperative evaluation protocol, including blood biochemisty, percutaneous
ultrasonography, computed tomography of the abdomen, and in selected patients
hepatic and superior mesenteric angiography.9
Liver function was assessed by both the Child“s-Pugh grading10
and the indocyanine green clearance test, as we reported previously.11
Two approaches were adopted for major right hepatic resection for large HCC
during the study period. In the conventional approach, the operation started
with a bilateral subcostal incision with or without an upward midline extension.
Intraoperative ultrasonography was performed routinely to delineate the extent
of tumor involvement, to detect tumor nodules in the contralateral lobe and
invasion of the tumor into major blood vessels, and to plan and mark the plane
of parenchymal transection. Liver hilar dissection was performed and the right
hepatic artery and portal vein were controlled. The right lobe of liver,
together with the tumor, was then completely mobilized from the posterior
abdominal wall and rotated anteriorly and to the left to allow separation of the
liver from the inferior vena cava. All the small caval venous branches were
individually ligated and divided. The right hepatic vein was then isolated
outside the liver, clamped, divided, and sutured. When difficulty was
encountered in some patients during mobilization of the right lobe of liver as a
result of the huge tumor size, adhesion, or tumor infiltration to the posterior
abdominal structures, the abdominal incision was extended into the right
thoracic cavity to allow space for the mobilization. Hepatic parenchymal
transection was performed after complete control of both the inflow and outflow
vessels of the right lobe of liver.
The anterior approach was used in selected patients with large HCC involving
the right lobe of liver and infiltrating the posterior abdominal structures or
the diaphragm. The decision for anterior approach was entirely determined by the
operating surgeon at the time of laparotomy when mobilization of the tumor
before parenchymal transection was considered dangerous, difficult, or
impossible. After laparotomy through a bilateral subcostal incision and hilar
dissection to control the right hepatic artery and portal vein, as in the
conventional approach, mobilization of the tumor and the right lobe of liver was
not performed. The plane of parenchymal transection, depending on the extent of
hepatic resection, was marked on the Glisson capsule with the help of
intraoperative ultrasonography. The transection was performed from the anterior
surface of the liver down to the right side of liver hilum and down to the
anterior surface of the inferior vena cava, which was completely exposed. If
concomitant caudate lobectomy was performed, the entire caudate lobe was
completely mobilized from the inferior vena cava and retracted toward the right
to be resected together with the main specimen. The small caval venous branches
were then individually ligated and the right hepatic vein was isolated, clamped,
divided, and sutured outside the liver parenchyma. When the specimen was
completely disconnected from the inferior vena cava, the right hepatic lobe was
mobilized from the right abdominal cavity by dividing the triangular ligament
and was delivered (Fig.
1).
 |
Figure 1. (A) Computed tomography scan showing the direction
and line of parenchymal transection in the anterior approach for a large
right-lobe hepatocellular carcinoma. (B) Intraoperative diagram of the
anterior approach for major right hepatic resection for large
hepatocellular carcinoma. Complete hepatic parenchymal transection is
performed down to the caudate lobe, and the middle hepatic vein is
transected. (C) Intraoperative diagram showing complete transection of
hepatic parenchyma and mobilization of the caudate lobe from the
inferior vena cava, which is completely exposed. (D) Intraoperative
diagram showing completion of hepatic resection and delivery of the
specimen. (C, caudate lobe; IVC, inferior vena cava; (LHV, left hepatic
vein; MHV, middle hepatic vein; RHV, right hepatic vein)
|
All patients received the same postoperative care by the same team of
surgeons and were nursed in the intensive care unit during the early
postoperative course. Parenteral nutritional support was provided for patients
with liver cirrhosis.12
Early enteric nutrition was encouraged once bowel activity returned. All
intraoperative and postoperative complications were recorded prospectively.
Hospital death was defined as death during the hospital stay for the hepatic
resection. Disease-free survival was calculated from the date of hepatic
resection to the date when recurrence was diagnosed.
Statistical analysis was performed by chi-square test or the Fisher exact
test to compare discrete variables, and the Mann-Whitney test was used to
compare continuous variables. Survival analysis, including cumulative survival
and disease-free survival, was estimated by the Kaplan-Meier survival method.
Statistical comparison of survival distributions was analyzed by log-rank tests.
Multivariate analysis by the Cox proportional hazard regression model was used
to identify independent prognostic factors in predicting overall cumulative
survival. P < .05 was considered to indicate statistical significance.
Statistical analyses were performed with SPSS for Windows computer software (SPSS
Inc., Chicago, IL).
RESULTS
Of the 330 patients who underwent hepatic resection for HCC between January
1989 and December 1997, 160 underwent major right hepatic resection for tumors
larger than 5 cm in diameter. The technique of anterior approach was used in 54
patients (33.8%) and the conventional approach was used in 106 patients (66.2%).
The clinical and laboratory data were comparable in both groups (Table
1), except that there were more men in the conventional approach group. The
median size of the tumors was 10.3 cm in the anterior approach group and was
comparable to that in the conventional approach group (10.5 cm, P =
.455). The pathologic data, including tumor-node-metastasis (TNM) staging,13
were comparable in both groups (Table
2). The extent of hepatic resection in both groups of patients is listed in
Table 3. Hepatic resection appeared more extensive in the anterior approach group
than in the conventional approach group because concomitant caudate lobe
resection was significantly more frequently performed (29.6% vs. 1.9%, P
< .001). To mobilize the tumor and to control the right hepatic vein before
parenchymal resection, thoracotomy was required in 15 patients in the
conventional approach group.
 |
Table 1. CLINICAL AND LABORATORY DATA |
 |
Table 2. PATHOLOGIC DATA
|
 |
Table 3. TYPE OF HEPATIC RESECTION |
The duration of surgery was comparable in the two groups (Table
4). The incidence of intraoperative iatrogenic tumor rupture during
mobilization of the right lobe of liver appeared to be higher in the
conventional approach group (seven patients, 6.6%) than the anterior approach
group (one patient, 1.9 %), although the difference was not significant (P
= .268). Intraoperative blood loss and blood transfusion requirement were both
significantly less and the number of patients without transfusion was also
significantly larger in the anterior approach group. The surgical complication
rate was comparable in both groups. None of the patients in the anterior
approach group died, and all the 14 hospital deaths occurred in the conventional
group. The cause of death was liver failure (four patients), intraabdominal
sepsis (four patients), chest infection (two patients), heart failure (one
patient), intraperitoneal bleeding (one patient), iatrogenic cardiac tamponade
from a misplaced central line (one patient), and rapid cancer progression in the
liver remnant (one patient).
 |
Table 4. INTRAOPERATIVE AND POSTOPERATIVE
DATA |
The median disease-free survival of the anterior approach group was 14.6
months and was significantly better than that of the conventional approach group
(5.6 months, P = .008) (Fig.
2). The median overall cumulative survival of the anterior approach group
was also significantly better than that of the conventional approach group (59.7
vs. 18.6 months, P = .016) (Fig.
3). On follow-up of the 92 patients in the conventional approach group who
did not die, pulmonary metastases developed in 41 (44.6%). The incidence was
significantly less in the anterior approach group, in which pulmonary metastases
developed in 12 (22.2%) of the 54 patients (P = .007). At the time of
writing, 33 patients remained disease-free with a median follow-up of 73 months:
17 patients (31.5%) were in the anterior approach group and 16 patients (15.1%)
were in the conventional group (P = .015).
 |
Figure 2. Disease-free survival of patients who underwent
major right hepatic resection using the anterior approach (54 patients)
and the conventional approach (106 patients).
|
Variables that might affect overall cumulative survival of the entire patient
population in this study (i.e., tumor size, TNM stage, blood loss volume, blood
transfusion, venous invasion in the HCC, and use of anterior approach) were
subjected to Cox regression analysis. The TNM stage, use of anterior approach,
tumor size, and intraoperative blood loss volume were found to be independent
factors influencing the overall cumulative survival (Table
5).
 |
Table 5. FACTORS AFFECTING OVERALL CUMULATIVE SURVIVAL
|
DISCUSSION
Despite recent reports on the satisfactory outcome of hepatectomy for HCC,14-16
major right hepatic resection for large HCC remains a major surgical challenge,
especially when underlying liver cirrhosis is present.17-20
With the conventional approach, complications may arise during difficult
mobilization of the right lobe of liver, leading to unfavorable surgical
outcomes. The anterior approach was first described by Ozawa21
as one of the "nonconventional approaches" to advanced liver cancer in
an attempt to avoid prolonged rotation and displacement of the hepatic lobes,
causing impairment of the afferent and efferent circulation. In the current
report, the technique of anterior approach was shown to result in favorable
surgical and long-term survival outcomes of the patients who underwent major
right hepatic resection for large HCC compared with those using the conventional
approach. The better outcome might be related to the reduction in blood loss,
because excessive intraoperative bleeding has been reported to have a
detrimental effect on the postoperative liver function and to result in an
increased perioperative death rate.22,23
Perioperative transfusion has also been found to promote recurrence of HCC after
hepatic resection, resulting in short disease-free and overall survivals.24,25
HCC is well known to be a soft, friable, and highly vascular tumor. Forceful
retraction of large right-lobe HCC during difficult mobilization using the
conventional approach can result in rupture of the tumor. This usually leads to
excessive bleeding and tumor cell spillage into the peritoneal cavity. As a
reaction to the ongoing bleeding from intraoperative tumor rupture, the hepatic
resection is usually performed in a hurry and may lead to further excessive
bleeding. However, when the anterior approach is used, the right lobe of the
liver, together with the tumor, is completely separated from the inferior vena
cava before mobilization. Therefore, mobilization can be performed from all
directions, including the medial aspect. Mobilization of the tumor from
retroperitoneal adhesion or infiltration, if present, can then be performed
quickly. Resection of adjacent structures, including the diaphragm or the right
adrenal gland, can also be performed at this stage if necessary.
Hematogenous dissemination of malignant tumor cells has been reported during
surgical resection of biliary-pancreatic cancer,26,27
colorectal cancer28
and prostatic cancer.29
It was considered related to manipulation of the tumors during surgery, and the
"no-touch" isolation technique has been reported to reduce
intraoperative shedding of tumor cells into the portal vein during resection of
colorectal cancer.30 In patients with HCC, venous permeation or vascular invasion of the tumor is
common.31,32
This phenomenon may be responsible for the high incidence of hematogenous spread
before resection, but compression of the tumor during mobilization may enhance
the spread of tumor cells into the systemic circulation33,34
or the intrahepatic portal venous system.35
The potential risk of tumor cell dissemination can theoretically be minimized
with use of the anterior approach. However, in this retrospective study, we did
not assess the presence of cancer cells in the circulation, such as positive
reverse transcription polymerase chain reaction alpha fetoprotein mRNA. Such
evidence should be evaluated in a prospective randomized trial.
Another deficiency of the present retrospective study is the fact that there
were more patients with TNM stage IVA disease in the conventional approach
group. TNM stage was shown to be a major determinant of long-term survival of
HCC after hepatectomy.36,37
To define the role of the anterior approach, multivariate analysis was
performed, and the anterior approach was found to be one of the independently
significant factors affecting long-term survival. Comparison of survival
according to tumor stage was not performed in this study because the numbers in
each subgroup were relatively small and uneven in distribution. In the future
prospective randomized trial, randomization by stratification according to TNM
stage should be performed to validate that anterior approach does improve the
result of hepatectomy in all TNM stages of HCC.
The duration of surgery was comparable in both groups of patients, although
more patients in the anterior approach group had concomitant caudate lobe
resection. In the anterior approach group, to avoid hepatic vein injury
resulting in excessive bleeding, extreme care had to be taken during parenchymal
transection using the ultrasonic dissector. This often resulted in prolonged
transection time. In the conventional approach group, however, more time was
spent in hemostasis and difficult mobilization of the tumor before parenchymal
transection, which sometimes required thoracotomy for adequate exposure.
Despite its advantages over the conventional approach, the anterior approach
is potentially dangerous. Torrential bleeding can occur at the deeper plane of
parenchymal transection (e.g., from the middle hepatic vein) and can be
difficult to control. Without prior mobilization of the right lobe of liver and
the tumor, the hepatic lobe cannot be lifted up and compressed manually for
hemostasis or rapid transection. Therefore, we had previously recommended that
this approach should be reserved for tumor invading the hepatic vein.9
Given the results of the present study, our view is modified. The anterior
approach might be the preferred technique if adequate experience in liver
transection has been accumulated, parenchymal transection is performed with
extreme care, and venous bleeding is controlled promptly with fine sutures.
In conclusion, the anterior approach was the preferred technique for major
right hepatic resection for large HCC because it resulted in improved surgical
and survival outcomes. Further studies are required to document the advantages
of the anterior approach as a routine technique for all right hepatic resections
for HCC and other hepatic tumors, ideally in a prospective randomized trial.
References
- Starzl TE, Bell RH, Beart RW, Putnam CW. Hepatic trisegmentectomy and
other liver resections. Surg Gynecol Obstet 1975;141:429-437.
- Fortner JG, Kim DK, Maclean BJ, et al. Major hepatic resection for
neoplasia: personal experience in 108 patients. Ann Surg
1978;188:363-371.
- Schwartz SI. Right hepatic lobectomy. Am J Surg 1984;148:668-673.
- Blumgart LH. Liver resection: liver and biliary tumours. In: Blumgart LH,
ed. Surgery of the Liver and Biliary Tract, 2d ed. London: Churchill
Livingstone; 1994: 1495-1537.
- Makuuchi M, Yamamoto J, Takayama T, et al. Extrahepatic division of the
right hepatic vein in hepatectomy. Hepatogastroenterology
1991;38:176-179.
- Ozawa K. Hepatic function and liver resection. J Gastroenterol Hepatol
1990;5:296-309.
- Lai ECS, Fan ST, Lo CM, et al. Anterior approach for difficult major
right hepatectomy. World J Surg 1996;20:314-318.
- Couinaud C. Le Foie. Etudes Anatomiques et Chirurgicales. Paris: Masson;
1957.
- Fan ST, Lo CM, Liu CL, et al. Hepatectomy for hepatocellular carcinoma:
toward zero hospital deaths. Ann Surg 1999;229:322-330.
- Pugh RNH, Murray-Lyon IM, Dawson JL, et al. Transection of the
oesophagus for bleeding varices. Br J Surg 1973;60:646-649.
- Fan ST, Lai ECS, Lo CM, et al. Hospital mortality of major hepatectomy
for hepatocellular carcinoma associated with cirrhosis. Arch Surg
1995;130:198-203.
- Fan ST, Lo CM, Lai ECS, et al. Perioperative nutritional support in
patients undergoing hepatectomy for hepatocellular carcinoma. N Engl J Med
1994;331:1547-1552.
- Sobin LH, Wittekind CH. TNM Classification of Malignant Tumours, 5th ed.
New York: Wiley-Liss; 1997: 74-77.
- Kosuge T, Makuuchi M, Takayama T, et al. Long-term results after
resection of hepatocellular carcinoma: experience of 480 cases.
Hepatogastroenterology 1993;40:328-332.
- Nagasue N, Kohno H, Chang YC, et al. Liver resection for hepatocellular
carcinoma: results of 229 consecutive patients during 11 years. Ann Surg
1993;217:375-384.
- Makuuchi M, Takayama T, Kubota K, et al. Hepatic resection for
hepatocellular carcinoma: Japanese experience. Hepatogastroenterology
1998;45:1267-1274.
- Nagasue N, Yukaya H, Kohno H, et al. Morbidity and mortality after major
hepatic resection in cirrhotic patients with hepatocellular carcinoma. HPB
Surg 1988;1:45-56.
- Bozzetti F, Gennari L, Regalia E, et al. Morbidity and mortality after
surgical resection of liver tumors: analysis of 229 cases.
Hepatogastroenterology 1992;39:237-241.
- Capussotti L, Polastri R. Operative risks of major hepatic resections.
Hepatogastroenterology 1998;45:184-190.
- Farges O, Malassagne B, Flejou JF, et al. Risk of major liver resection
in patients with underlying chronic liver disease: a reappraisal. Ann Surg
1999;229:210-215.
- Ozawa K. Nonconventional approaches to advanced liver cancer. In: Liver
Surgery Approached Through the Mitochondria. Tokyo: Medical Tribune; 1992:
117-165.
- Nagao T, Goto S, Kawano N, et al. Hepatic resection for hepatocellular
carcinoma. Clinical features and long-term prognosis. Ann Surg
1987;205:33-40.
- Tjandra JJ, Fan ST, Wong J. Perioperative mortality in hepatic
resection. Austral NZ J Surg 1991;61:201-206.
- Yamamoto J, Kosuge T, Takayama T, et al. Perioperative blood transfusion
promotes recurrence of hepatocellular carcinoma after hepatectomy. Surgery
1994;115:303-309.
- Matsumata T, Ikeda Y, Hayashi H, et al. The association between
transfusion and cancer-free survival after curative resection for
hepatocellular carcinoma. Cancer 1993;72:1866-1871.
- Nomoto S, Nakao A, Kasai Y, et al. Detection of ras gene mutations in
perioperative peripheral blood with pancreatic adenocarcinoma. Jpn J
Cancer Res 1996;87:793-797.
- Miyazono F, Takao S, Natsugoe S, et al. Molecular detection of
circulating cancer cells during surgery in patients with
biliary-pancreatic cancer. Am J Surg 1999;177:475-479.
- Weitz J, Kienle P, Lacroix J, et al. Dissemination of tumor cells in
patients undergoing surgery for colorectal cancer. Clin Cancer Res
1998;4:343-348.
- Oefelein MG, Kaul K, Herz B, et al. Molecular detection of prostate
epithelial cells from the surgical field and peripheral circulation during
radical prostatectomy. J Urol 1996;155:238-242.
- Hayashi N, Egami H, Kai M, et al. No-touch isolation technique reduces
intraoperative shedding of tumor cells into the portal vein during
resection of colorectal cancer. Surgery 1999;125:369-374.
- Ng IOL, Lai ECS, Ng MMT, Fan ST. Tumor encapsulation in hepatocellular
carcinoma: a pathologic study of 189 cases. Cancer 1992;70:45-49.
- Vauthey JN, Klimstra D, Franceschi D, et al. Factors affecting long-term
outcome after hepatic resection for hepatocellular carcinoma. Am J Surg
1995;169:28-34.
- Koo J, Fung K, Siu KF, et al. Recovery of malignant tumor cells from the
right atrium during hepatic resection for hepatocellular carcinoma. Cancer
1983;52:1952-1956.
- Louha M, Nicolet J, Zylberberg H, et al. Liver resection and needle
liver biopsy cause hematogenous dissemination of liver cells. Hepatology
1999;29:879-882.
- Matsumata T, Kanematsu T, Takenaka K, Sugimachi K. Lack of intrahepatic
recurrence of hepatocellular carcinoma by temporary portal venous
embolization with starch microspheres. Surgery 1989;105:188-191.
- Suenaga M, Nakao A, Harada A, et al. Hepatic resection for
hepatocellular carcinoma. World J Surg 1992;16:97-104.
- Takenaka K, Kawahara N, Yamamoto K, et al. Results of 280 liver
resections for hepatocellular carcinoma. Arch Surg 1996;131:71-76.
Ann Surg 2000 July;232(1):25-31
|